Amy Zhang highlights the early stages of AI integration into healthcare, particularly digital biology, where the intersection of life science and computational technology creates a golden age for data-advantaged companies. She points to Guardant Health (GH) and its Infinity AI platform as a standout in the liquid biopsy space.